Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism
about
Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection.Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's diseaseThe cerebrospinal fluid proteome in HIV infection: change associated with disease severityCerebrospinal fluid proteome of patients with acute Lyme diseaseAltered concentrations of amyloid precursor protein metabolites in the cerebrospinal fluid of patients with bipolar disorderCerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease.Ex vivo 18O-labeling mass spectrometry identifies a peripheral amyloid β clearance pathwayCerebrospinal fluid biomarkers for Alzheimer disease and subcortical axonal damage in 5,542 clinical samplesCSF biomarkers in neurodegenerative diseases.Amyloidogenic amyloid-β-peptide variants induce microbial agglutination and exert antimicrobial activity.Clinical determinants of Lyme borreliosis, babesiosis, bartonellosis, anaplasmosis, and ehrlichiosis in an Australian cohortAssociation of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease ProgressionClinical use of cerebrospinal fluid biomarkers in Alzheimer's disease.Cerebrospinal fluid profiles of amyloid β-related biomarkers in Alzheimer's disease.Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies.Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections.A Specific Reduction in Aβ1-42 vs. a Universal Loss of Aβ Peptides in CSF Differentiates Alzheimer's Disease From Meningitis and Multiple Sclerosis.The Physiological Roles of Amyloid-β Peptide Hint at New Ways to Treat Alzheimer's Disease.
P2860
Q34776835-AE95B42E-9C4C-459B-B8DD-07A412A0CC2FQ35119389-ECCBF3B9-9486-4F2D-8DE0-CD23971DED3FQ35965332-F8CBBFFE-0BCC-40CD-95C5-44C15C233111Q36301174-578F155D-9001-4FE0-941F-4612FEE7B42CQ36610063-E45E1905-7B64-45FB-A33F-C4A7A2AA7E79Q37307467-0DC34C51-A1C6-46B1-BC97-1AFC75CCE4EFQ37652424-DCC6778F-A6E5-4D92-9607-2BAEE9792853Q37690301-417ED12B-BB27-4B4B-9038-76EC97B64BDFQ37837903-D66AA8CA-EE3D-4EC3-8EE7-39E0759F0427Q39394951-7BBAB03F-A084-4566-A0E4-2C95CB81C94FQ41558997-2D678CD0-C7C9-4A32-8A12-9EECB333B55EQ42287644-42E0D5F9-31FC-4B7E-8E8B-06F29D351B01Q48400950-CC771E50-1EE8-4355-A886-07153B0191F4Q48650878-476DB1DF-0BCD-4325-BF70-233BEB0245A5Q50666330-30C3FCF1-A1F9-4284-B6A7-71BE60F02354Q53333738-F9CA41F7-607F-40B7-B738-3EA98CD02AC4Q55002822-2005F902-3344-4417-81F1-A36DBE0FFD74Q55411317-ACCCFB71-76F8-458C-95EF-2131BF205058
P2860
Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism
@ast
Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism
@en
type
label
Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism
@ast
Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism
@en
prefLabel
Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism
@ast
Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism
@en
P2093
P2860
P50
P356
P1433
P1476
Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism
@en
P2093
Daniel Bremell
Lars Hagberg
Rolf Anckarsäter
P2860
P2888
P356
10.1186/1471-2377-10-51
P577
2010-06-22T00:00:00Z
P5875
P6179
1003596528